At Lipp Life Sciences LLC, I focus on patient-centered innovation and advise clients in the life sciences and health care industries.I have been serving in leadership positions in the life sciences industry for more than 30 years. As Chief Scientific Officer at Noven Pharmaceuticals I provided leadership to all research and development areas. At Schering in Germany and later at Eli Lilly in the US I headed various R&D functions with increasing responsibility for people and budget – up to 450 FTEs and up to $250 million.My expertise covers new chemical entities, biologics, devices, combination products and the areas of medicinal chemistry, pharmaceutical R&D and drug delivery, process development, analytical R&D, toxicology, clinical pharmacology, clinical R&D, regulatory affairs and pharmacovigilance, medical affairs, and commercial. My scientific contributions comprise more than 140 publications, including over 20 patents, covering five marketed medicines with aggregate peak annual sales exceeding $1 billion.I am a pharmacist and hold a Ph.D. in Medicinal Chemistry and a Habilitation for Pharmaceutical Technology from Free University Berlin, Germany. I graduated from the International Executive Program, at INSEAD in Fontainebleau, France and from the Advanced Management Program, at Harvard Business School, Boston, MA, USA.